Table 2.
Subjects’ Baseline Characteristics with Any Urinary Incontinence & Severe Urinary Incontinence* & Predictors of Progression to Severe Urinary Incontinence and Improvement of Severe Urinary Incontinence
| Subjects with Any UI N=2187 |
Subjects with Severe UI N=650 |
Predictors Severe UI Progression Odds Ratio (95% CI) | Predictors Severe UI Improvement Odds Ratio (95% CI) | |
|---|---|---|---|---|
|
| ||||
| Decade Life | ||||
| 5th decade | 35.5% (777/2187) | 26.8% (174/650) | Reference group | Reference group |
| 6th decade | 22.6% (495/2187) | 24.2% (157/650) | 1.21 (0.97–1.52) | 0.70 (0.45–1.10) |
| 7th decade | 30.3% (663/2187) | 33.7% (219/650) | 1.84 (1.50–2.26) | 0.61 (0.40–0.91) |
| 8th decade | 10.6% (231/2187) | 13.5% (88/650) | 3.69 (2.84–4.78) | 0.28 (0.16–0.49) |
| 9th decade | 1.0% (21/2187) | 1.9% (12/650) | 6.06 (3.43–10.68) | 0.12 (0.02–0.57) |
|
| ||||
| Ethnicity | ||||
| White | 83.5% (1825/2187) | 84.0% (546/650) | Reference group | |
| African American | 10.3% (225/2187) | 10.2% (66/650) | 0.57 (0.45–0.73) | |
| Hispanic | 4.8% (105/2187) | 4.5% (29/650) | 0.67 (0.49–0.92) | |
| Other | 1.5%(32/2187) | 1.4% ( 9/650) | 1.16 (0.68–1.97) | |
|
| ||||
| Parity* | ||||
| 0 | 10.3% (222/2160) | 8.4% (54/640 | Reference group | |
| 1 | 10.4%(225/2160) | 12.0%(77/640) | 0.71 (0.51–1.00) | |
| 2 | 24.5%(530/2160) | 23.3%(149/640) | 0.77 (0.58–1.03) | |
| >2 | 54.8%(1183/2160) | 56.3%(360/640) | 1.08 (0.84–1.39) | |
|
| ||||
| # Medical Co-morbidities | ||||
| 0 | 18.1%(395/2187) | 12.5% (81/650) | Reference group | |
| 1 | 28.5%(624/2187) | 25.4% (165/650) | 0.92 (0.72–1.17) | |
| 2 | 27.3%(596/2187) | 27.7% (180/650) | 1.32 (1.03–1.69) | |
| ≥3 | 26.2%(572/2187) | 34.5% (224/650) | 1.61 (1.23–2.10) | |
|
| ||||
| BMI (kg/m2) | ||||
| <25 | 34.0% (743/2187) | 27.7% (180/650) | Reference group | Reference group |
| ≥25 to <30 | 33.8% (740/2187) | 32.0% (208/650) | 1.21 (1.00–1.46) | 0.72(0.48–1.10) |
| ≥30 to <35 | 19.9% (436/2187) | 22.8% (148/650) | 1.12 (0.88–1.42) | 0.66 (0.42–1.05) |
| ≥35 | 12.3% (268/2187 | 17.5% (114/650) | 1.82 (1.38–2.41) | 0.45 (0.27–0.74) |
|
| ||||
| Psychiatric History | ||||
| No | 75.9%(1659/2187) | 74.6% (485/650) | Reference group | |
| Yes | 24.1% (528/2187) | 25.4% (165/650) | 1.64 (1.35–1.99) | |
|
| ||||
| Functional Limitations | ||||
| None | 20.4% (447/2187) | 14.5% (94/650) | Reference group | |
| ≥0 and ≤25% limited | 22.0% (480/2187) | 17.2% (112/650) | 1.37 (1.07–1.76) | |
| >25% | 57.6% (1260/2187) | 68.3% (444/650) | 2.36 (1.89–2.94) | |
*
See text Results section, paragraph 5